Alexza Pharmaceuticals: Warming Up or Cooling Off? (ALXA)

Alexza Pharmaceuticals: Warming Up or Cooling Off?

By Motley Fool Staff | More Articles
July 29, 2010 | Comments (0)

Watch stocks you care about

The single, easiest way to keep track of all the stocks that matter...

Your own personalized stock watchlist!

It's a 100% FREE Motley Fool service...

Click Here Now

Together, we are all trying to build our fortunes by finding well-run companies at bargain-basement prices. But it takes work to scour earnings reports, scrutinize key data, and assess the competition.

To help you out, we've created a screen based on the massive data aggregated from the more than 165,000 investors competing on our Motley Fool CAPS platform. Each quarter, we check in on select companies after they file a 10-Q and track community sentiment to help you see how your company is doing.

Here's our CAPS community's sentiment on Alexza Pharmaceuticals (Nasdaq: ALXA ) both for this quarter and last (for comparison), as well as opinions on some related companies.

Metric	Alexza Pharmaceuticals	Acura Pharmaceuticals (Nasdaq: ACUR )	POZEN (Nasdaq: POZN )	Biovail (NYSE: BVF )
This Quarter (7/28/2010):
Price:	$2.80	$2.83	$8.01	$21.98
% of Members Rating Outperform	91%	58%	85%	92%
% of All-Star Members Rating Outperform	90%	50%	77%	92%
CAPS Rating (out of 5)
Last Quarter (4/29/2010):
Price:	$3.38	$3.67	$12.08	$16.84
% of Members Rating Outperform	88%	59%	78%	93%
% of All-Star Members Rating Outperform	91%	57%	68%	94%
CAPS Rating (out of 5)

Source: Motley Fool CAPS. Dates given are the posting dates of Alexza Pharmaceuticals' most recent quarterly and/or annual reports to the SEC's website. Percentages are calculated from the number of members rating each company.

A change in the community's approval (signified by four- and five-star ratings) or disapproval (one- and two-star ratings) could indicate that further research is in order. To help make your research easier…

Share any thoughts you have about Alexza Pharmaceuticals -- or any of the other companies mentioned -- in the comments box below.
Head over to the completely free CAPS service -- a one-stop research shop -- and read what your fellow investors are saying about your stocks.

Best Odds in the Universe!
If you're interested in a 98.79% chance at beating the market... and a 70.84% chance at DOUBLING the market's return – Motley Fool Supernova could be just what you're looking for. And get this: We arrived at these odds from 10,000 random back-tested portfolios composed of Motley Fool Co-founder David Gardner's personal stock picks.

It's why David recently handpicked a small team of world-class portfolio managers. You see, he thinks these odds can get even better! And he'd like to prove it to you...

Simply enter your email address. And the answer to the question everybody is asking will be delivered to your inbox!

Because this was built from a screen, no individual person selected the stocks in this article, so there is no author to disclose an interest in them. Since this article was automatically generated by identifying the stocks loved both by the CAPS community and by buyers in today's market, it is possible that Motley Fool personnel (and even The Motley Fool itself, through our Million Dollar Portfolio, Hidden Gems, Motley Fool Pro, and Ready Made Millionaire services) have positions in these stocks. We thought you'd like to know that. Learn more about The Motley Fool's disclosure policy.

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment icon found on every comment.